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Type 2 diabetes mellitus is a chronic disease affecting 26 million people in the 
United States or 8.3% of the population.  The prevalence of diabetes is rapidly increasing 
and increases with age. Treatment guidelines for Type 2 diabetes mellitus have been 
developed by the American Diabetes Association (2015) to decrease mortality and 
morbidity in patients with the disease.  Utilization of current guidelines is a major 
component of providing evidence-based care.  With the advent and widespread usage of 
electronic health records (EHR), a vehicle for point-of-care inclusion of accepted 
standardized guidelines exists.  Including a reminder alert system within an existing EHR 
triggers providers to comply with current guidelines.  Implementation of such a reminder 
system within a rural family medicine practice increased compliance with established 
guidelines.  The guidelines measured in this study were blood pressure measurement at 
last visit, measurement of glycosylated hemoglobin within the last six months, and 
prescribed statin pharmacologic therapy.  Glycosylated hemoglobin measurement 
increased by 16%, blood pressure measurement improved by 13%, and treatment with 
statin therapy increased by 16%.  Implications for practice are inclusion of other Type 2 
diabetes mellitus guidelines into the reminder alert system.  Expansion of this system to 
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include other chronic diseases with accepted evidence based guidelines may be designed 
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Introduction and Background 
 
Management of complex clinical information is required in the care of the patient 
with diabetes.  Use of an electronic health record (EHR) has the potential to improve this 
information management and, thus, the quality of care and outcomes of patients with 
diabetes.  Institution of a diabetes disease management system within the EHR to 
improve patient care was the goal of this project.  
A rural family practice medical clinic instituted an EHR system in 2012—
Healthland (2016).  Institution of the software has slowly progressed and includes the 
capability to utilize clinic and provider specific modifications.  The capability to add 
diagnosis-specific decision support tools is also possible.  Reminder systems have been 
studied and data reviewed for the purpose of instituting such a system in this rural family 
medical practice.  Implementing the capability of the software was a component of this 
disease management system project. 
Prior to the conversion to EHR, a card was kept in each diabetic patient’s paper 
chart.  It contained patient care guidelines and a spreadsheet for provider documentation 
of guideline compliance and a visual aid to view trends in measurements (see Appendix 
A).  When the EHR conversion occurred, there was no process to continue the previous 
method for guideline use and monitor compliance and outcomes of treatment.  An easy to 
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use process of tracking guideline compliance that incorporates an automatic prompt 
would be highly valuable for care of patients with diabetes in this setting.  
Use of such a software reminder system also has value in quality measures and 
statistical compilations of clinical outcomes.  The Affordable Care Act U.S. Department 
of Health and Human Services [USHHS], 2012) requires the reporting of some of this 
information and the groundwork was established by the proactive integration of a 
software reminder system in the EHR to achieve the required reporting.  The Affordable 
Care Act also proposes payment based on guideline outcome ratings (USHHS, 2012, pp.  
613-642).  The practice can use this system to measure provider compliance with disease 
management guidelines as well as motivate improvement for financial gain. 
In the near future, the impact of chronic illness on health and increasing health 
care costs will require the use of stronger evidence, better tools, and more effective 
practice systems. This could be a major step in this medical practice for improved chronic 
disease management.  
Research Question 
 The following research question guided this study: 
Q1 Can the design and implementation of a diabetes management clinical  
decision support tool in to an existing electronic health record improve 
compliance with established evidence-based guidelines?  
 
Background and Significance of Project 
Diabetes is a group of metabolic diseases marked by hyperglycemia, resulting 
from deficits in insulin secretion, insulin action, or both.  It occurs when the body no 
longer responds effectively to endogenous insulin or when the body’s production of 
insulin is inadequate.  Chronic hyperglycemia leads to abnormal metabolism of 
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carbohydrates, fats, and proteins.  This chronic hyperglycemia of diabetes is associated 
with long-term damage, dysfunction, and organ failure.  
Abnormal pancreatic islet cell function is a key and requisite component of Type 
2 diabetes mellitus (T2DM) pathology.  In early disease stages, insulin production is 
normal or increased in absolute terms but disproportionately low for the degree of insulin 
sensitivity, which is typically reduced in T2DM.  Insulin kinetics such as the ability of 
the pancreatic beta-cell to release adequate hormone in response to rising glycemia are 
profoundly compromised.  In T2DM, pancreatic alpha-cells hypersecrete glucagon, 
promoting hepatic gluconeogenesis; glycogen is converted to glucose creating 
hyperglycemia.  Glucagon secretion is not suppressed in the pancreatic cell dysfunction 
of pre-diabetes and T2DM and hepatic glucose production rises; the counter-regulatory 
mechanisms between insulin and glucagon do not work.  A post-prandial increase in 
glucose concentration occurs despite an initial threefold increase in endogenous insulin 
production.  This intensifies insulin resistance. 
In most patients with T2DM, especially the obese, insulin resistance in target 
tissues (liver, muscle, adipose tissue, and myocardium) is a prominent feature.  Insulin 
resistance results from defective glucose utilization within peripheral target organs and is 
most pronounced in skeletal muscle cells.  The result is both glucose overproduction and 
underutilization.  Elevated levels of plasma glucose become cytotoxic and lead to loss of 
beta-cell function and mass.  The ability of the beta-cells to produce optimal insulin 
levels eventually fails due to apoptosis caused by the exposure to increasing plasma 
hyperglycemia (Unger, 2013).  
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An increased delivery of fatty acids to the liver favors their oxidation, thereby 
contributing to increased gluconeogenesis and the overabundance of lipids, promoting 
hepatosteatosis.  More recently, incretin system abnormalities have also been found in 
T2DM.  The incretin defect, which is also believed to be due to a resistance, results in 
increased glucagon secretion, fails to delay gastric emptying, reduces satiety, and 
promotes adipocytes to store triglycerides.  Obesity develops.  
Hyperglycemia leads to microvascular diseases: retinopathy, nephropathy, and 
neuropathy.  It also contributes to premature macrovascular disease: stroke and 
myocardial infarction.  Complications of diabetes are a major source of morbidity in the 
United States: the development of premature coronary heart disease, stroke, peripheral 
vascular disease, renal failure, and amputation (Unger, 2013). 
Both genetic and environmental factors lead to the development of T2DM.  The 
most dominant determinant seems to be one’s body mass index; weight reduction and 
increased physical activity can therefore serve to delay or prevent the development of 
T2DM.  The Diabetes Prevention Program (Centers for Disease Control and Prevention 
[CDC], 1996), one of the largest randomized clinical trials, resulted in the reduction of 
T2DM by up to 71% utilizing lifestyle interventions.  Multiple pharmacologic therapies 
can delay the progression of T2DM and its complications.  In addition to 
pharmacological therapies, reducing risk in T2DM involves the effective implementation 
of lifestyle behaviors that prevent or slow the progression of diabetes complications. 
Although diabetes care processes and outcomes have improved over the past 10 years, 
currently one of five persons with diabetes has poor glycemic control, one of three has 
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poor blood pressure control, and two of five have poor low-density lipoprotein (LDL) 
cholesterol control (Boren, Gunlock, Schaefer, & Albright, 2007). 
National, Regional, and Local Statistics 
“The global epidemic of T2DM is one of the major public health problem of the 
21st century and the fifth leading cause of death worldwide” (Sanghera & Blackett, 2012, 
p. 1).  In 2011, the number of people in the United States with diabetes reached nearly 26 
million or 8.3% of the population.  The prevalence of diabetes increases with age: 26.9% 
of people aged 60 years or older have diabetes--more than one in four.  The Center for 
Disease Control (2007) predicts if current trends continue, one in three people born in 
2000 will eventually develop diabetes.  With increasing numbers of the obese, the 
elderly, and high-risk minority groups in the population, prevalence is increasing. 
In Nebraska, the site of this rural family practice clinic, as well as in the rest of 
the United States, the prevalence of diabetes is increasing.  According to 2008 data 
collected by the Behavioral Risk Factor Surveillance System (Nebraska Diabetes 
Prevention Program [DPP], 2010), the number of Nebraska residents age 18 years and 
older with diagnosed diabetes is estimated at 103,000--7.8% of the state’s adult 
population, which is slightly below the national median of 8.3%.  Behavioral Risk Factor 
Surveillance System data indicate there are over 63,000 adults in Nebraska who have 
been diagnosed with pre-diabetes.  Two trends in Nebraska suggest the size of 
Nebraska’s diabetic population is unlikely to decrease: (a) the increase in the incidence of 
obesity is accompanied by an increase in diabetes and Nebraska’s prevalence of obesity 
has doubled in less than two decades and (b) the risk of diabetes increases with age and 
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Nebraska’s population is getting older with 17.2% of Nebraska residents currently 65 or 
older. 
Financial Impact 
The global costs of T2DM are expected to increase from $376 billion in 2010 to 
$490 billion in 2030 (Sanghera & Blackett, 2012).  The financial burden of diabetes was 
$174 billion in 2007 (Shahady et al., 2012).  Costs continue to grow.  In 2012, the 
estimated total economic cost was $245 billion, a 41% increase based on 2007 data 
(Yang et al., 2013).  This estimate contained $176 billion in direct medical costs and $69 
billion in reduced productivity (CDC, 2007).  Direct medical expenses are composed of 
hospital in-patient care, prescription medications to treat the complications of diabetes, 
antidiabetic agents and diabetic supplies, physician office visits, and nursing/residential 
facility stays.  Indirect costs include those of increased absenteeism and reduced 
productivity while at work for the employed population, reduced productivity for those 
not in the workforce, inability to work as a result of a disease-related disability, and lost 
productive capacity due to early mortality. 
Those diagnosed with diabetes have medical expenditures approximately 2.3 
times higher than those without diabetes.  Care for individuals diagnosed with diabetes 
accounts for more than one in five healthcare dollars in the United States; more than half 
of that is directly attributable to diabetes (Yang et al., 2013). 
Diabetes Guidelines 
The American Diabetes Association (ADA; 2015) linked suboptimal diabetes 
mellitus care to fragmentation of healthcare delivery systems and called for innovative, 
evidence-based, patient-centered care.  The ADA guidelines advocate effective 
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interventions including provider education, diabetes mellitus self-management education, 
guideline-based checklists, point-of-care availability of guidelines, automated reminders, 
dedicated diabetes mellitus provider visits, diabetes mellitus registries, care management 
services, and specialty consultation (ADA, 2015; Singh & Haas, 2006) 
Multiple guidelines for the treatment of T2DM have been published.  American 
Diabetes Association (2012) guidelines include recommendations that include screening, 
diagnosis, and therapeutic actions known or believed to favorably affect health outcomes 
of patients with diabetes.  A summary and comparison of the major sources including 
ADA and the American College of Endocrinology guidelines reveal they are very similar 
(Fisher & Kapustin, 2007).  The Standards of Medical Care in Diabetes were revised in 
January of 2015 (ADA, 2015).  Included in the guidelines are diagnosis, screening, 
classification, evaluation, management, prevention education, glycemic targets, screening 
for microvascular complications, cardiovascular disease, and risk management with 
specific population considerations.  The primary objective of these clinical guidelines 
was to recommend clinical minimum standards of care based on scientific evidence and 
expert opinion.   
The American Association of Diabetes Educators (Haas et al., 2013) also has 
standards for risk assessment and risk reduction to prevent or slow the progression of 
diabetes complications.  These guidelines contain available references for the different 
components of T2DM standard adherence. These components can be divided into 
processes of care, treatment, and outcomes.  Because quality care is multidimensional, it 
requires many different measures.  
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Processes of care provide quantitative indicators for improvements in care and the 
methods by which quality care is provided.  Indicator measurement and monitoring make 
it possible to document quality of care and make comparisons over time between places. 
They also make it possible to make judgements and set priorities while supporting 
accountability.  For this project, these processes of care involved those actions occurring 
at a routine primary care clinic visit such as measurements done or resulting from 
primary care ordered laboratory measurements.  They are based on research evidence.  
The ADA (2015) is generally considered the United States’ standard and was used for the 
purposes of this work.  Processes of care included but were not limited to obtaining 
glycated hemoglobin level (HgbA1C), blood pressure determinations, fasting lipid 
panels, testing for urine albumin secretion with a spot urine albumin-to-creatinine ratio, 
and assuring the medication treatment included a statin and anti-platelet therapy.  Process 
of care outcomes frequently chosen are based on their relationship to intermediate 
outcomes (Crossan et al., 2007).   
Treatment consists of implementing an intervention for documented processes as 
recommended in guidelines.  Treatments would include medication to treat an elevated 
HgA1C or an elevated blood pressure.  
Outcomes include HbA1C>8%, and blood pressure <140/90.  These outcomes are 
intermediate outcomes based on evidence that long-term complications are reduced when 
these outcomes are achieved.  Awareness of target goals should be contained within the 
reminder system. 
There is evidence to suggest systems developed in-house might lead practices to 
improve their adherence to guidelines and there is less evidence that commercially 
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developed systems improve adherence to clinical guidelines.  Studies indicated support 
systems engineered by those who used the flow of care already in place within the 
specific EHR utilized had higher composite scores of desired clinical outcomes as well as 
higher scores of patient satisfaction with their provider (Holbrook et al., 2009).  Provider 
compliance and utilization improved when a decision support system did not require 
making a web based connection during the visit or entering data more than once because 
the system was not fully integrated.  Technical difficulties with cumbersome systems 
created negative provider perceptions and lower compliance scores.  Systems that had 
patient notification systems linked to these guidelines had high patient and provider 
scores (Holbrook et al., 2009). 
Electronic Health Record and Clinical Support Tools 
Use of an EHR in ambulatory care settings has been widely recommended as a 
method for reducing errors, improving the quality of health care, and reducing costs.  In 
the treatment of chronic diseases, use of an EHR is expected to increase quality by 
facilitating the management of complex clinical information, support evidence-based 
clinical decision making, lead to lower rates of missing clinical information, and improve 
the coordination of tasks among members of the healthcare team. 
Current evidence evaluating EHR effectiveness was derived from a few 
intervention studies and from case study reports.  Some studies documented improved 
diabetes patient outcomes after EHR usage, whereas others showed improvements in the 
process of diabetes care but not in patient outcomes (Costa, Fitzgerald, Jones, & 
Dunning, 2009).  A randomized trial that assessed the impact of an electronic health 
record-based diabetes clinical decision support system on control of A1C, blood pressure, 
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and LDL cholesterol levels in adults with diabetes found significant improvement in A1C 
and some aspects of blood pressure control (O’Connor et al., 2011).  This study also 
found 94% physician satisfaction with the system; moderate use of the support system 
persisted for more than one year (O’Connor et al., 2011). 
Efforts to expand EHR usage in chronic care call for a methodology that not only 
focuses on technology but on the providing, implementing, and integrating information 
and guidelines into practice.  The ability of EHR mechanisms to improve communication 
among health professionals and patients is apparent; constraints cited related to such 
implementation were frequently time and staff shortages (Costa et al., 2009).   
Theoretical Framework 
The theoretical foundation for this capstone project was the chronic care model 
(CCM).  The CCM uses a systematic approach to restructuring medical care to create 
partnerships between health systems and communities.  This approach is needed in our 
changing health care system and is especially applicable to chronic disease management. 
Wagner, Austin, and Von Korff (1996) developed this theory in the 1990s when they saw 
our system of treating acute episodic illness lacked a means to manage chronic disease.  
Proof has been offered for the ability of the CCM to improve chronic care outcomes 
(Mason, Levitt, & Chaffee, 2012).   
The CCM was developed to improve patient health outcomes by changing the 
way ambulatory care is being delivered through six system change processes that focus 
on the implementation of patient-centered, evidence-based care.  The aim of the CCM is 
to transform the daily care for patients with chronic illnesses from acute and reactive to 
proactive, planned, and population-based.  It is designed to accomplish these goals 
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through a combination of effective team care and planned interactions; self-management 
support bolstered by more effective use of community resources; integrated decision 
support; and patient registries and other supportive information technology (Coleman, 
Austin, Brach, & Wagner, 2009).  
An analysis of studies published since 2000 supported the CCM design as a 
method for improved patient care and health outcomes (Coleman et al., 2009).  The CCM 
summarizes the basic elements for improving care in health systems at the community, 
organization, practice, and patient levels.  It identifies essential elements of a healthcare 
system that encourages high-quality care of patients with chronic diseases: the 
community, the health system, self-management support, delivery system design, 
decision support, and clinical information systems (see Appendix B). 
Encouragement of active engagement of patients in self-management has been 
shown to improve effectiveness and outcomes.  Specific elements of methods to produce 
these outcomes are difficult to determine from existing data.  Use of the CCM might 
provide an avenue for producing desired outcomes.  High-performing healthcare 
organizations more often use different CCM components for successful outcomes: 
computerize reminders for patients and providers (clinical information systems), involve 
practitioners on quality improvement teams (healthcare organizations), incorporate 
guidelines supported by clinician education or computer support (decision support), 
provide patients with formal self-management programs (self-management support), and 
utilize a registry (clinical information systems; Coleman et al., 2009).  Disease registries 
in the EHR can be used to establish patient-centered goals, monitor patient progress, and 
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identify lapses in care.  The CCM has been used for diabetes care in primary care settings 
with positive outcomes reported (Stellefson, Dipnarine, & Stopka, 2013). 
The particular focus for this project was the clinical information systems 
component with a goal to organize patient and population data to facilitate efficient and 
effective care.  Effective chronic illness care is virtually impossible without information 
systems that assure ready access to key data on individual patients as well as populations 
of patients.  A comprehensive clinical information system can enhance the care of 
individual patients by providing reminders and data summaries can help track care and 
outcomes.  At the practice population level, an information system can also identify 
groups of patients needing additional care.  These systems might be used for performance 
monitoring and quality improvement assessment.  
With the signing of the Affordable Care Act in 2010 (USHHS, 2012), changes 
were created in our reimbursement infrastructures that are proving to advance models of 
prevention and chronic care provision.  Grants were provided for pilot programs to 
evaluate chronic disease risk factors, conduct evidence-based public health interventions, 
and ensure individuals identified with chronic disease or at-risk for chronic disease 
received clinical treatment to reduce risk (Anderko et al., 2012).  Meaningful use criteria 
derived from the ACA included several T2DM measures: HbA1C control, retinal eye 
exam, urine screening, foot exam, LDL management and control, and blood pressure 
management (Centers for Medicare & Medicaid Services, n.d.). 
Project Objectives 
There were three objectives for this capstone project: (a) use current EBP 
guidelines for T2DM to design an EHR disease management support reminder system 
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specific for this rural practice and EHR system, (b) implement an EHR disease 
management support program for T2DM within the functioning EHR, and (c) assess for 
change in compliance with established guidelines for T2DM diseases within the EHR. 
The purpose of this project was to improve T2DM care using the EHR across a 
rural family practice clinic.  Fashioning an electronic reminder system that replaces the 
current paper guideline (see Appendix A) used prior to the implementation of the EHR 
was intended to meet the identified need.  Use of this system to measure disease 
management guideline compliance while improving processes of care and ultimately 
improving patient clinical outcomes was the goal of this project.    
Summary 
Type 2 diabetes mellitus is a chronic metabolic disease affecting significant 
numbers of patients.  The financial impact to health care as well as the prevalence of 
T2DM is increasing.  The continuing growth and financial impact of T2DM provide an 
impetus to consider incorporation of an EHR reminder alert system based on the CCM to 
improve outcomes in T2DM while facilitating adherence to the most current guidelines 
for T2DM. 
Studies evaluating the effectiveness of the CCM in chronic care have shown use 
of this framework could result in improved outcomes.  The paradigm shift from acute 
care visits to a prevention-based system not delivered in isolated visits could be more 
effective (Piatt et al., 2006).  Patients’ clinical, behavioral, psychological and diabetes 
knowledge outcomes improve with this shift in focus and use of the CCM.  Systematic 
reviews consistently showed improvement in at least one process or outcome measure. 
Studies evaluating cost savings with systems that used the CCM for diabetes have shown 
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mixed results: in part, this is due to an inability to measure savings in reducing long-term 
complications.  An analysis conducted by Bodenheimer, Wagoner, and Grumbach (2002) 
showed a reduction in Emergency Department visits as well as reductions in hospital 
stays.  These results were similar to a study conducted by Adams et al. (2007) on chronic 
obstructive pulmonary disease and the CCM.  Pooled data demonstrated patients with 
chronic obstructive pulmonary disease who received interventions with two or more 
CCM components had lower rates of hospitalization, emergency and unscheduled visits, 















LITERATURE REVIEW AND PROJECT DESCRIPTION  
 
 
Literature Review Parameters 
 
A literature search was conducted using the keywords of diabetes guidelines, 
T2DM, EHR clinical decision support tools and glycemic control.  Databases included in 
this search were CINAHL, The Cochrane Library (which includes The Cochrane 
Database of Systematic Reviews, The Cochrane Register of Controlled Trials, and The 
Cochrane methodology Register), the U.S. Department of Health & Human Services 
Agency for Healthcare Research and Quality, Medline, and Google Scholar.  Sources 
from the American Diabetes Association (2015) were also used.   
The search produced 74 articles and 24 articles were deemed relevant and used in 
this review.  Quality, similarity and boundaries of included studies were based on the 
specificity of the research question.  Inclusion criteria were those studies published in the 
English language in peer-reviewed sources.  Study inclusion criteria included those 
written since 2005.  Relevancy was initially determined by the inclusion of one or more 
key words.  Population similarities were considered as well as the similarity of 
intervention.  The outcome measurement included glycemic control.  Exclusion criteria 
included those studies that did not target clinical practice or did not include a description 




Summary, Critical Review, and  
Synthesis of Literature 
During and after this review, the significance and the impact of improved control 
of T2DM were well documented with multiple published guidelines for treatment. It was 
also noted there were many studies using EHR systems for improved patient care.  
Conflicting results were related to the actual improvement of outcomes versus the 
improvement of process and documentation. 
The Diabetes Prevention Program (CDC, 1996), a large study documenting the 
delay and prevention of T2DM in those with pre-diabetes, instituted lifestyle 
modifications with significant success.  This was one of several pilot programs started in 
the United States in response to the directives set forth in the Affordable Care Act 
(USHHS, 2012).  The original study was funded by the National Institutes of Health and 
supported by the Centers for Disease Control and Prevention.  The study demonstrated 
that making certain lifestyle changes and continuing them over time could prevent T2DM 
in people who are at risk.  The potential for using this project to successfully identify, 
follow, and treat pre-diabetes is high in clinical practice.  Measurement for meaningful 
use could be applicable.  
A Cochrane review (Duke, Colaquiri, & Colaquiri, 2009) analyzed diabetes 
education and its impact on a number of outcomes including glycemic control and basic 
physical measures.  The included studies were too short to assess long-term 
complications and cost effectiveness was not addressed.  A primary outcome common to 
these studies was glycemic control measured by glycated hemoglobin (HgA1C).  
Secondary outcomes measured were physical measure of body mass index, blood 
pressure (BP), and lipids.  The studies were divided to compare typical care to individual 
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care.  There was no statistically significant change in glycemic control in any of the 
studies where baseline HbA1C was less than 8%.  Concurrently, there were no 
improvements in physical measures either.  Two included studies looked at self-
management outcomes of diet and exercise management; one of them showed 
statistically significant improvements in body mass index.   
No systematic reviews were found on the use of clinical decision support tools 
within the EHR.  Many studies outside the time guidelines included represented the EHR 
as an effective tool to introduce practice guidelines into clinical settings as well as some 
data to validate the EHR as an effective medium for the evaluation of practice guidelines 
and their effect on patient outcomes. 
Veterans Affairs (Nilasena & Lincoln, 1995) used computer-generated reminders 
as a way to improve compliance with diabetes prevention guidelines.  Their data 
suggested the computer system improved care by facilitating documentation of guidelines 
and the ordering of recommended procedures or testing.  This randomized controlled trial 
encompassed information from the medical history, physical exam, laboratory results, 
referrals, and patient education.  Improvement in all compliance scores was seen; an 
average of 16.6% improvement in compliance scores was found.  Again, the long-term 
effects of outcomes of the diabetic patient were not able to be measured.  This study 
discussed the issue of over-compliance such as more frequent ordering of laboratory tests 
such as HbA1C and lipid levels.  Costs were increased with over-compliance; Nilasena 
and Lincoln (1995) postulated some providers did blood tests at every encounter in a 
shotgun type approach rather than following guideline intervals.  They made no 
speculation on the effect this might have on diabetic complications.  
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These process measures did not necessarily translate into outcome improvement 
in morbidity and mortality.  An identified need for more long-term studies was found. 
Although complication rates decreased as HgA1C decreased, there were still instances 
where equivalent HgA1C levels had varying manifestations of diabetic complications. 
Also in question were premises within the guidelines themselves; lower HgA1C and LDL 
levels might not directly represent improved diabetes care.  Determining whether lower 
levels were a function of medical treatment, patient motivation, or genetics was difficult.  
Yet the real dilemma remained in the process of activating patients.  Using this 
information for clinic visit planning or outreach activation might be an area deserving 
focus.  With current changes in healthcare, this information will be required and 
measured; its use remains to be seen.  
The Mayo Health Systems Diabetes Translation Project (Montori, Dinneen, 
Gorman, Zimmerman, & Rizza, 2002) found planned care augmented by the EHR led to 
improved performance and metabolic outcomes in diabetes care.  This study was of 
interest due to the length of study--24 months; most other EHR studies were six months 
or shorter.  They also identified information from the use of clinical decision support 
tools influenced the practice management decision implementation to facilitate 
improvements in metabolic control, medication changes, or other strategies.  
A systematic review (Kawamoto, Houlihan, Balas, & Lobach, 2005) of trials of 
clinical decision support systems identified features critical to success.  Seventy studies 
were included in the analysis and found decision support systems improved clinical 
practice in 68% of the trials.  System features that were likely to improve clinical practice 
were automatic provision of decision support as part of clinical workflow, provision of 
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recommendations rather than just assessments, provision of decision support at time and 
location of decision-making, and computer- based decision support (Kawamoto et al., 
2005). 
Multiple studies related to diabetes management and telehealth have been done 
and indicate the potential for improved self-care.  The relevance of these studies to EHR 
use related to meaningful use and patient portal communication.  If providers could 
electronically communicate and provide educational materials to patients in response to 
their access to their laboratory results or their diabetes questions, providers met 
meaningful use criteria with automated supporting documentation and the potential to 
measure outcome changes.  Studies in underserved populations reported improved 
metabolic control with some reduction in cardiovascular risk. 
A cross-sectional analysis of 50 practices at the New Jersey Medical School, 
which examined the use of the EHR and diabetes quality care, found insufficient 
evidence that process, treatment, and intermediate outcomes were improved with EHR 
usage (Crossan et al., 2007).  Crossan et al. (2007) suggested implementing new health 
information technologies without attention to work flow redesign might create quality 
problems in patient care.  
Wrobel et al. (2011) evaluated the use of an EHR registry for foot care that 
showed improved discrimination of the highest foot risk.  This improvement was made 
via a dialogue tick box containing the International Diabetic Foot Classification System 
to improve the accuracy of coding foot risk (Wrobel et al, 2011).  This dialogue tick box 
required the provider to mark an “X” when positive findings occurred and a free text 
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template note was automatically populated in the record.  This led to better coding for 
patients with Grade 3 foot risk.  
Summary 
The literature review supported the main components of this capstone: (a) the use 
of accepted guidelines in evidence-based practice (EBP) improved outcomes in T2DM, 
(b) EHR usage has the potential to improve quality of care in T2DM and compliance with 
guidelines, and (c) a practice-specific reminder system increases the chance for 
compliance with guidelines and documentation.  Reviews indicated longer studies are 
needed.  Long-term studies of T2DM might provide evidence for mortality and morbidity 

















The setting was a rural health clinic in Nebraska (see Appendix C).  This clinical 
practice included two satellite clinics and a critical access hospital.  The ambulatory 
providers provided care at both satellite clinics.  This network was a county non-profit 
system and was the only provider of health care in the county.  The medical staff was 
composed of two physicians, one physician assistant, and two nurse practitioners.  The 
nursing staff consisted of a nurse manager and six licensed practical nurses.  One of these 
nurses served as the clinic’s information technology super user or EHR specialist. 
The population of the county is 4,889 with 3.5 persons per square mile and 
considered a rural, sparsely populated area.  The median per capita income is 
$21,881with 14.7% below the poverty level.  The population over the age of 65 is 18.1% 
and predominately White (U.S. Census Bureau [USCB], 2012).  
Morrill County has a diabetes incidence of 9.2%, which is greater than the 
Nebraska rate of 7.9%.  The rural clinic has a population of 3,216 patients; 9.4% of these 
have a diagnosis of diabetes (see Table 1).  Gender statistics showed 141 of the patients 







Age # of T2DM 
Patients 
Gender Male Gender Female 
<40     9    4    5 
40-75 167 68  99 
>75   59 22  37 
Total 235 94 141 
 
 
Evidence-Based Project Plan 
Use of current practice guidelines in the care of patients with T2DM was 
inconsistent, both within this practice and in the United States in general.  Incorporation 
of these guidelines in the current EHR might lead to improved outcomes and possible 
complication reduction and/or elimination.  Overall patient quality of life improvement as 
well as health care costs reduction might be the anticipated benefit of this project’s 
implementation.  
The rationale for this project was three-fold: reminder systems within the EHR 
have proven to improve guideline compliance; improved guideline compliance has 
resulted in decreased complications; and decreased complications resulting in cost 
reduction in emergency department and unscheduled clinic visits, decreased hospital 




Plan development consisted of establishing a reminder system, implementation of 
this reminder system, and assessment of any change after this implementation.  The 
reminder system consisted of an alert that automatically populated in a patient’s EHR 
when the current problem list contained T2DM.  Because this reminder was not based on 
the chief complaint of the current visit, an opportunity to remind those patients who 
might have been non-compliant with labs or BP monitoring presented itself.  This had the 
potential of increasing awareness of guidelines with both the provider and the patient. 
Since patient education is required at every visit, the provision of T2DM education at 
every visit might be more likely.  The reminder system included three main T2DM 
guidelines: blood pressure determination, HgbA1C measured within the last six months, 
and statin therapy for patients over 40 years of age.  
The rationale for blood pressure determination was based on the guideline that 
recommends, “Blood pressure should be measured at every routine visit. Patients found 
to have elevated blood pressure should have blood pressure confirmed on a separate day”  
(ADA, 2015, p. S49).  These recent guideline revisions adjusted the goal blood pressure 
to <140/90.  Treatment of elevated blood pressure should include lifestyle changes and 
pharmacological therapy that includes either an angiotension-converting enzyme inhibitor 
or an angiotension receptor blocker.    
Evaluation of glycemic control done by the measurement of HgbA1C performed 
on a sample of blood was recommended: 
Perform the A1C test at least two times a year in patients who are meeting 
treatment goals and who have stable glycemic control.  Perform the A1C test 
quarterly in patients whose therapy has changed or who are not meeting glycemic 
goals.  Use of point-of-care testing for A1C provides the opportunity for more 
timely treatment changes. (ADA, 2015, p. S34) 
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Recommendations for statin treatment were also included in the new 2015 ADA 
revision and came about after consideration of the American College of 
Cardiology/American Heart Association guidelines.  Because T2DM is considered a 
cardiovascular risk factor, statin therapy is advised on all patients over 40 years of age. 
The intensity of statin therapy recommended varied from moderate to high depending on 
the presence of other cardiovascular risk factors or the presence of overt cardiovascular 
disease (ADA, 2015, p. S52). 
Assessment of change was triggered by automatic report runs generated within 
the EHR.  These reports also served as another mechanism of improving awareness to 
providers.  Improved provider awareness might serve to translate to improved patient 
awareness about current guidelines or recommendations.  
Reminder triggers were (a) statin treatment, (b) blood pressure reading obtained at 
every routine visit, and (c) HgA1C measured within the last six months.  The reminder 
trigger for statin therapy recognized the absence of a statin and the provider had the 
opportunity to cite a reason that included an intolerance or patient refusal.  Blood 
pressure measurements were entered in the vitals tab to be captured.  The HgA1C 
measurements were from the generated order entry and lab portions of the EHR.  Labs 
done at any other facility and scanned into the document component were not measured. 
The provider, of course, at the time of receiving the automated reminder could verify the 
HgA1C measurement, although this was likely a rare circumstance.  If the patient refused 
having an HgA1C performed due to cost or other reason, it was not captured but could be 
documented in the health maintenance module.   
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Report generation documented statistics before and after implementation.  Outlier 
information captured within the EHR was summarized by the author.  During report 
generation for the purposes of clinic use and further reminders, trigger adaptation and use 
these statistics could be viewed for each specific provider included in the system. 
Statistics could also be viewed by gender and age of patient.  There was no mechanism in 
this capstone to measure the amount of HgA1C at goal.  There was also no mechanism to 
delineate those patients who might have had more than one HgA1C measured in the six-
month study period.  
The need for improved diabetic outcomes was well-documented.  Instituting a 
system for EBP/guidelines into the EHR was a need at this rural clinic.  A nurse from this 
clinic attended training by the EHR platform company.  Information was obtained about 
the specific feasibility of incorporating diabetes guidelines into the Healthland (2016) 
system; the system had the ability to add diabetes guidelines to the EHR.  
Before the advent of EHRs in the clinic, a paper diabetic checklist was used by 
some providers.  This list contained some of the current guideline criteria and served as a 
reminder for monitoring specific recommended aspects of diabetes care.  With the current 
system, there was no functional mechanism for guideline adherence, reminder, or alert 
system.  There is no easy way to continue to use paper checklists in an electronic health 
system.  Implementing an alert system for guidelines was the intended goal of this 
capstone project. 
A needs assessment for inclusion criteria was conducted.  A review of current 
guidelines resulted in a plethora of criteria.  Determination of the most important and 
useful guidelines and measurement of outcome, process, or guideline compliance was 
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completed.  Part of this inclusion of decision-making was dependent on the software 
capabilities.  This information was obtained during a software conference in October, 
2014.  Provider participation and input was obtained. 
Ethics and Human Subject Protection 
Exempt status approval was obtained from the Institutional Review Board of the 
University of Northern Colorado prior to conducting research at the supporting 
organization (see Appendix D). 
Timeline 
The timeline involved a two- to three-week period of software updates as well as 
training for necessary staff.  Use of the trigger alert system was over a six-month time 
period.  Data collection was done before and after implementation.  
Resources, Personnel, Technology, and Budget 
The resource was the clinic in this capstone as well as access to the EHR and the 
software.  Personnel involved were the informatics nurse, providers included in the study, 
and their nurses.  Coordination and contact with software support personnel was 
necessary.   
Evaluation Plan 
Evaluation was done after all data were collected.  Each of the three components 
was analyzed separately to compare data collected before project implementation and six 
months after the project.  The project as a whole was evaluated.  The nature of this 
evaluation was based on the data obtained.  Comments and/or suggestions of providers 
were included anecdotally.  Data were accessed by selected lab results (HgA1C), selected 
medications (statins), and selected vitals (blood pressure). 
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The IT nurse who collated and generated this report had the ability to view 
provider documentation if a measure was not obtained including patient refusal, HgA1C 
measured at another laboratory, statin intolerance including liver disease, and cost-
prohibition of obtaining laboratory tests or medication.  Patient non-compliance for 
unknown or personal reasons was categorized together.  
Results of this project could pave the way for further chronic and/or acute disease 
alert systems within the EHR.  Learning the effect of integrating EBP guidelines into 
practice via the EHR and capturing accurate measurements of compliance with these 
guidelines in the EHR were valuable.  Improving the quality of care to patients in this 
Nebraska practice was the ultimate goal.  
Reminder Design 
The reminder alert was designed within the Health Maintenance module of the 
Healthland (2016) platform.  This alert message was attached to all EHRs coded T2DM 
in the problem list of the patient.  It attached to both genders and patients 40 years of age 
or older.  The alert cue was a red exclamation point by the patient’s name when they had 
an open chart on a provider’s worklist.  When the provider opened that chart, the red 
exclamation point remained on the top following his/her name.  The provider clicked on 
the Health Maintenance section of the chart and the alert message appeared.  The alert 
















Results Linked to Problem Statement  
and Evaluation Plan 
The design and implementation of a diabetes management clinical decision 
support tool in an existing EHR improved compliance with established evidence-based 
guidelines.  Prior to the implementation of this project, the author, in conjunction with the 
IT nurse, obtained the total number of patients in this practice who had T2DM as a coded 
medical diagnosis.  The demographics of these patients were obtained.  These 
demographics were particularly relevant since the statin recommendation was dependent 
on age in T2DM. 
The reminder system was designed by the author with the assistance of an IT 
nurse employed by the clinic.  The reminder alert was designed within the Health 
Maintenance component of the software system.  Limitations were inherent within the 
software but many of these were known and considered before design occurred.  This 
trigger attached to any EHR in which T2DM was coded in the problem list.  The 
reminder alert automatically triggered whenever a patient with T2DM registered for any 
type of clinic visit.  This trigger could potentially be attached by gender and it was 
attached to both males and females.  The trigger could be attached by age and was 
attached to age greater than 40 years.  Data could be collected by selected labs and 
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HgA1C was the selected laboratory test.  Data could be collected by selected medications 
and all statins in the formulary were attached.  Data could also be collected by selected 
vitals and BP was selected.  The trigger appeared as a red exclamation point on the 
provider’s work list.  When the provider entered the patient’s chart, the red exclamation 
point appeared on the health maintenance component.  When the provider clicked on this, 
a drop-down box appeared.  This box included the link to the ADA (2012) guidelines.  
The provider was able to acknowledge the guideline or override and ignore it.  If the 
provider chose to acknowledge it, he/she then clicked on the box for procedure 
performed, patient refused, or discussed procedure with patient.  There was then a free 
textbox labeled reason.  If the provider chose to override the guideline, he/she could 
select a date to obtain the procedure or a box could be checked to always exclude the 
health maintenance reminder for this patient.  The term procedure was part of the 
software and could not be changed.  
One complication that occurred in the initial set-up was the pharmacy formulary. 
The clinic system is integrated with the hospital system and the hospital pharmacy 
formulary did not include rosuvastatin (Crestor).  The pharmacy had to write rosuvastatin 
into the formulary for it to be counted in data collection.  They did this for the purpose of 
this project; however, the hospital pharmacy does not stock rosuvastatin for in-patient 
use.  The consulting pharmacist and the medical staff dictated the formulary by class and 
cost.  The addition of rosuvastatin to the formulary took a small amount of time and 
resources and occurred on the days of initial set-up. 
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Adherence to established guidelines were measured for three components of the 
ADA (2012) guidelines: HgA1C, blood pressure measurements, and statin pharmacologic 
treatment.  Percentages were calculated both pre- and post-implementation (see Table 2).  
 
Table 2 
Components Measured per American Diabetes Association Guidelines 
Clinical Measure Pre-intervention #s (%) Post-intervention #s (%) 
HgA1C within 6 months 136 (57%) 167 (71%) 
BP at last visit 202 (86%) 233 (99%) 
Statin therapy (indicated 
only for patients >40) 




Sources of Data 
All data were collected from the EHR by the author with the assistance of the IT 
nurse employed in the clinic.  Prior to implementation of the project, 57% of included 
patients had HgA1C measurements, 86% had blood pressure measured and documented, 
and 50% of patients > 40 years old were on statin medication.  Following implementation 
of the reminder system 71% of T2DM patients had HgA1C measured, 99% had blood 
pressure recorded, and 53% were on statin therapy.  These increases were clinically 
significant and consistent with the national studies (Nilasena & Lincoln, 1995).  The 
number of patients with HgA1C values measured increased by 14% or 31 patients.  This 
increase in laboratory assessment often leads to increased patient awareness in overall 
control, can lead to provider implementation of increased or additional pharmacologic 
treatment, as well as reinforcement of lifestyle changes.  
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Blood pressure measurement increased by approximately the same amount.  This 
99% compliance gives the provider the opportunity to assess blood pressure control and 
add treatment.  The provider had the ability to access the link to ADA (2015) guidelines 
for blood pressure as well as treatment recommendations.  Utilization of this link by 
providers was not a part of the project however.  The prescribing of statin therapy 
increased the most--by 16%.  This guideline was one of the newest ADA 
recommendations and might be reflected in the increase; the opportunity to assess for and 
add a statin might have first presented itself during the study timeframe.  Increased use of 
statin therapy has the potential to lead to a decrease in vascular complications of T2DM. 
Key Facilitators and Barriers That Impacted  
Project’s Objectives 
A key facilitator to this project was the increased awareness created by this 
project’s institution in a small clinical network.  Providers and nurses were informed of 
guideline items included prior to project implementation.  This increased awareness 
served to facilitate discussions about these guidelines with patients on both levels of 
communication and education.  This potentially increased project success. 
Another facilitator was the clinics’ nursing staff.  Depending on provider 
preference and autonomy, nurses would acknowledge the guidelines and enter the date of 
the laboratory study or the date statin therapy was initiated.  Continuing this trend while 
adding guidelines to the reminder system also might have the potential to increase 
compliance and success.   
Another possible facilitator was a health fair.  Patients were able to obtain HgA1C 
levels outside the clinical setting; 20 vouchers were distributed by clinic providers for 
free lab work and those who had to pay did so at a greatly reduced cost.  These lab values 
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were not included in this project’s statistics but the diligence involved in propelling 
patients to obtain the measurements improved patient care, compliance with guidelines, 
and possible long-term outcomes.  Other pertinent laboratory studies were also done 
during this health fair that evaluated diabetic morbidity and, therefore, potentially 
improved patients’ outcomes.   
Multiple barriers might have had an impact on the achievement of this project’s 
objectives.  Barriers identified were patient or provider non-compliance, limitations 
within the software design, and the inability to capture laboratory study results when 
obtained at another facility.  Patients who were not seen in the clinic for any reason 
during the study had little chance of impact although the study results reflected current 
compliance with the studied T2DM guidelines.  Any patients with new T2DM diagnoses 
were not included.  
Barriers related to patient compliance were noted as patients’ refusal or failure to 
obtain recommended lab tests and/or take medications.  The reason for refusal was not 
consistently documented as the comment box was optional for the provider.  Some 
providers used this box but some did not enter a reason.  Non-compliance exceptions 
included cost of lab test or medications and side effects of statin therapy.  The decision to 
not make this a required field was to streamline the reminder alert system.  Most 
providers did document this reason within their chart notes but it was beyond the scope of 
this project to study and collate these data.  In retrospect, it would be this author’s 
recommendation to include the reason for exception as a required field.  This would make 
the guideline apparent, i.e., when or if another provider saw this patient, he/she would be 
able to easily access the reason for guideline non-compliance.  Addressing statin non-
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compliance could also be divided into those who truly had a side effect, those who had 
preconceived ideas about statin therapy and side effects, and those who just refused to 
take another medication.  
Provider non-compliance was difficult to define.  Informal discussions with the 
providers identified several issues; the most common was lack of time while trying to 
hurry and finish chart notes, accidental incompletion, or attempting to institute an interval 
override to change the date of laboratory measurement for patient convenience or 
coinciding with other tests.  One possible way of addressing this issue would be repetitive 
discussions at weekly medical utilization review meetings or routine provider compliance 
reports.  
Barriers inherent within the software design were items within the drop box that 
could not be changed or modified.  To acknowledge the guideline recommendation, the 
provider must enter the date completed and check a box reporting the procedure was 
performed for the guideline to be acknowledged.  If a patient was at a face-to-face visit 
and they were going to do lab on that day or in the next few days, some providers went 
ahead and acknowledged it and some did not.  As this study evolved, some providers had 
their nurses acknowledge the guideline if the patient was there for a T2DM visit and a 
recent lab was known to be done.  Thus, project success might have increased during the 
study period as providers and the staff became more familiar with the process.  
Although this project successfully increased ADA (2015) guideline adherence, 
there remains room for improvement.  Given the reasons for statin therapy and obtaining 
HgA1C measurements were not consistently easy to access, compliance was not at or 
near 100%.  Blood pressure measurements were very close at 99%.  Making the reason 
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for non-compliance mandatory as stated above might complete the data picture.  Because 
the statin medication therapy and laboratory measurement of the HbA1C involved patient 
compliance, it would not be expected that rates would be at 100%.  
 During the study period of this project, additional reminder trigger alerts were 
added for prostate specific antigen (PSA) measurement on men over 50 and this might 
have distracted from the project and increased alert fatigue.  Alert fatigue increases as the 
number of required fields increase in an EHR, resulting in desensitization and increased 
probability of provider noncompliance.  This PSA recommendation was added by IT as a 
meaningful health maintenance item.  
 Those patients who were not compliant with laboratory testing due to cost were 
given vouchers for an upcoming health fair; thus, HgbA1C compliance might have been 
even higher had these results been within the timeline of this project.  A method for 
capturing these laboratory tests would need to be developed further.  Because these 
laboratory results were performed by an outside laboratory, they were scanned into the 
EHR and not in the laboratory section where they could be part of the reminder alert 
system.  
Implementation of an EHR Type 2 diabetes management program and outcomes 
in a rural practice resulted in improved compliance with evidence-based guidelines 
established by the American Diabetes Association (2015).  Specifically measured were 
HbA1C measurements obtained at least every six months, blood pressure measured at 
every clinic visit, and pharmacologic treatment with a statin in patients over age 40 years 
with T2DM as a coded medical problem.  
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Patients with Hg1C measures improved by 14%.  Documented indications for 
non-compliance were cost and patient refusal or no show.  This improvement was a 
reasonable expectation for the first six months of the reminder alert system. Data 
collected in this study did not include the number of clinic visits made by the 235 
patients.  There is a callback system to remind patients when laboratory tests are due and 
a mechanism to ensure patients are seen at least yearly.  The six-month study of this 
project did not necessarily include all of those yearly visits although most patients are 
seen much more frequently than that.  Patients might have had laboratory studies done 
but might not have been seen in the clinic; they might have received a communication 
from their provider about the results.  If they were not seen in the clinic, it was less likely 
a statin would have been started without that face-to-face visit.  Thus, the trigger alert 
system would not help with patients who were not seen.   
Blood pressure measurements were obtained 99% of visits--an increase of 13%. 
Pre-implementation statistics were good; thus, the increase was of lesser significance. 
Control of blood pressure was not measured nor was the treatment with an angiotensin 
inhibitor or angiotension II receptor blocker.  
Treatment with statin pharmacologic therapy increased by16%.  Documentation 
captured for non-compliance revealed statin intolerance was the major reason.  

















Recommendations Related to Problem Statement,  
Supporting Organization, Key Stakeholders,  
and Student  
 
Recommendations related to the problem statement would be the inclusion of a 
larger spectrum of the established guidelines.  Goals pertaining to the inclusion of 
multiple guidelines of different measure would complicate computer run reports but 
could possibly be established with advanced IT assistance.  Adding a mechanism to 
assess the rate of blood pressure readings at goal could be done; one would need to 
decide if all readings obtained within the time period would needed to be at goal and if 
there was a way to take extraneous conditions contributing to elevations into 
consideration 
Inclusion of a monofilament exam of feet could be included although a consistent 
area within the EHR would need to be provided.  A yearly ophthalmic examination is 
recommended and a method of assessing this could also be included.  Angiotensin 
inhibitor use or angiotension II receptor blocker could be assessed as well as anti-platelet 
therapy.  
Since many patients have perceptions about statin therapy based on opinion rather 
than experience, discussion with their provider might dispel some but not all of these 
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misconceptions.  Multiple cost and insurance factors influence a patient’s compliance 
with recommended mediations: different rates of co-pay amounts for different statins, the 
prices vary from pharmacy to pharmacy, and limited insurance selection.  Cash pay 
patients most often choose the cheapest alternative or might choose not to take some 
recommended medications.  This rural clinic network has a prescription assistance 
program wherein a nurse helps with the submission of application forms to drug 
companies who have patient assistance programs for those with low incomes.  
Availability and income qualifications vary from company to company.  
At the current time, the supporting organization does not have the budget for 
manpower to spend on IT development along this particular avenue.  This author plans to 
assist the IT nurse with small, gradual incremental changes.  The EHR platform does not 
have support staff available in a very timely manner for assistance and the staff responds 
with assistance erratically.  A recommendation has been made for increased budgeting 
for design and development of further EHR reminder systems.  
At another time, these statistics could be analyzed on a provider-specific basis. 
Providers could be given their compliance rates in an effort to facilitate increased 
compliance with guidelines.  These statistics could also be adapted to quality assessment 
studies as well as used in insurance reviews.  
Recommendations Within Framework of  
Organization’s Strategic Plan 
The supporting organization was limited within the EHR Healthland (2016) 
platform; network support was limited and often lengthy but could perhaps be facilitated 
with administrative support and perseverance.  Administration and philosophy supported 
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compliance with accepted guidelines as well as compliance with meaningful use criteria 
and insurers’ quality measures. 
A barrier to this project was identified and had effects along at least two avenues: 
laboratory costs for obtaining the HgbA1C.  In the clinical network where this project 
was implemented, many patients did not comply with laboratory studies due to cost.  A 
health fair every year offered laboratory tests at a greatly reduced cost and these clinics 
had 20 vouchers for free laboratory tests.  Unfortunately, this health fair was not 
conducted during the time period of this study.  Because the results obtained were not 
done at the integrated laboratory, anyone who used the health fair for obtaining their 
HgbA1C was not included in the result statistics.  Because these results were scanned 
into the EHR, they were searched by individual EHR number and compiled manually.  A 
possible change in how these results are incorporated into the EHR or developing a 
possible way to have the report runs recognize these documents could add to a future 
study or quality assessment.  In-house HgA1Cs were not possible at this institution.  
Some home monitors were becoming available for home performance of the HgA1C.  
The nurse for this author became familiar with this complication and put the date in the 
health maintenance reminder system when a lab from an outside facility or the health fair 
was signed and sent to be scanned into the document section of the EHR, improving the 
retrieval rate of patient-specific information and thus improving care. 
Another improvement in this project would be the ability of the EHR to automatically 
capture the laboratory results. Currently, providers must manually acknowledge a 
laboratory test has been completed.  Adapting the program to automatically capture 
laboratory tests would be a significant advantage.  However, at this point in time, this 
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does not seem likely.  The author and her nurse, together with the laboratory manager, are 
working on a way to have the laboratory result or its electronically signed order 
automatically acknowledge completion of the test.  Adding this task to the clinic nursing 
staff is a consideration; some nurses are already doing this although it is not an accepted 
procedure at the current time.  
Contribution to Personal Goals in Advanced  
Practice Nursing 
The focus on evidence-based practice was a hallmark of this project and 
awareness of such was highlighted for all providers in this practice.  The ability to 
measure and document compliance advanced the goals of advanced practice nursing also. 
Assessment of improvement in practice is an ongoing goal and motivational factor.  With 
the increasing complexity and volume of practice guidelines and the amount of insurance 
reimbursement based on guideline compliance, having increased reporting capabilities 
built into EHR systems is valuable for quality patient care as well as productivity for 
healthcare providers and healthcare systems.  
This experience has implications for the rural Nebraska practice network used for 
this study.  Multiple chronic diseases have accepted guidelines.  These guidelines are 
continually updated and revised.  Having guideline access at the time of patient contact 
would improve provider recommendations and patient compliance.  Continued utilization 
of this alert trigger and development of additional alert triggers for other chronic illnesses 
are planned for this practice.  The experience with the EHR software platform, 
developing a reminder trigger system, and evaluating their use is advantageous to current 





Type 2 diabetes mellitus is a chronic disease and is the fifth leading cause of 
death worldwide.  The rapidly increasing prevalence of T2DM and its significant 
financial burden make medical treatment a priority in primary care. The use of an EHR in 
ambulatory care has increased the ability to facilitate management of complex clinical 
information and support evidence-based clinical decision-making.  Expanding EHR 
usage in chronic care to integrate current practice guidelines has the potential to improve 
quality care and the outcomes of those patients with T2DM.  Development of a system to 
do this within a current EHR platform was the focus of this project.  A trigger reminder 
system was implemented in a rural Nebraska family practice network and improved 
compliance with accepted ADA (2015) guidelines in three processes of diabetes care: 
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